CD28 and neoplasm: Given that the expression of CD28 is markedly higher in primary tumor tissues than in healthy tissues, T lymphocyte activity might be inhibited in tumor tissue [7], which results in an immune-suppressed microenvironment that participates in endowing cells with oncogenic functions.